CD5 and diffuse large B-cell lymphoma: Themajority of CD5+ DLBCL cases belong to the activated B-cell subtype ofDLBCL.11,12 Clinically, this molecular subtype of DLBCL follows anaggressive clinical course similar to T-cell lymphomas.13